{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T02:17:26Z","timestamp":1791512246208,"version":"4.3.4"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.coi.2026.102735","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T20:06:10Z","timestamp":1770840370000},"page":"102735","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Rheumatoid arthritis: revisiting pathogenesis for prevention, stratification, and repair"],"prefix":"10.1016","volume":"99","author":[{"given":"Fr\u00e9d\u00e9ric","family":"Coutant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Miossec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2026.102735_bib1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/rheumatology\/keae544","article-title":"Difficult-to-treat rheumatoid arthritis: what have we learned and what do we still need to learn?","volume":"64","author":"Hofman","year":"2025","journal-title":"Rheumatology"},{"key":"10.1016\/j.coi.2026.102735_bib2","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1136\/ard.2009.124537","article-title":"Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis","volume":"69","author":"van der Woude","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2026.102735_bib3","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1136\/ard-2023-225237","article-title":"Shift in perspective: autoimmunity protecting against rheumatoid arthritis","volume":"83","author":"He","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2026.102735_bib4","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/s41584-021-00665-4","article-title":"Importance of lymphocyte-stromal cell interactions in autoimmune and inflammatory rheumatic diseases","volume":"17","author":"Noack","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.coi.2026.102735_bib5","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41584-024-01154-0","article-title":"Distinct mucosal endotypes as initiators and drivers of rheumatoid arthritis","volume":"20","author":"Holers","year":"2024","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.coi.2026.102735_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2025.103775","article-title":"Mucosal immunity and rheumatoid arthritis: an update on mechanisms and therapeutic potential","volume":"24","author":"Yang","year":"2025","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.coi.2026.102735_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2024.105822","article-title":"From a better knowledge of periodontal disease to Porphyromonas gingivalis target for rheumatoid arthritis disease activity","volume":"92","author":"Dalix","year":"2025","journal-title":"Jt Bone Spine"},{"key":"10.1016\/j.coi.2026.102735_bib8","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/art.41948","article-title":"Association of sputum neutrophil extracellular trap subsets with IgA anti-citrullinated protein antibodies in subjects at risk for rheumatoid arthritis","volume":"74","author":"Okamoto","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.coi.2026.102735_bib9","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/art.40920","article-title":"N-linked glycans in the variable domain of IgG anti-citrullinated protein antibodies predict the development of rheumatoid arthritis","volume":"71","author":"Hafkenscheid","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.coi.2026.102735_bib10","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.jbspin.2019.01.005","article-title":"Pathogenic effects of anti-citrullinated protein antibodies in rheumatoid arthritis \u2013 role for glycosylation","volume":"86","author":"Coutant","year":"2019","journal-title":"Jt Bone Spine"},{"key":"10.1016\/j.coi.2026.102735_bib11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/art.42679","article-title":"Anti-citrullinated protein antibodies with multiple specificities ameliorate collagen antibody-induced arthritis in a time-dependent manner","volume":"76","author":"Gomez","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.coi.2026.102735_bib12","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2023.2281763","article-title":"Anti-citrullinated histone monoclonal antibody CIT-013, a dual action therapeutic for neutrophil extracellular trap-associated autoimmune diseases","volume":"15","author":"van der Linden","year":"2023","journal-title":"MAbs"},{"key":"10.1016\/j.coi.2026.102735_bib13","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1172\/JCI60975","article-title":"Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin","volume":"122","author":"Harre","year":"2012","journal-title":"J Clin Investig"},{"key":"10.1016\/j.coi.2026.102735_bib14","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/jbmr.3158","article-title":"Periarticular bone loss in arthritis is induced by autoantibodies against citrullinated vimentin","volume":"32","author":"Engdahl","year":"2017","journal-title":"J Bone Min Res"},{"key":"10.1016\/j.coi.2026.102735_bib15","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1136\/annrheumdis-2018-214967","article-title":"Anticitrullinated protein antibodies facilitate migration of synovial tissue-derived fibroblasts","volume":"78","author":"Sun","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2026.102735_bib16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/BOR.0000000000000664","article-title":"Evolving concepts of the pathogenesis of rheumatoid arthritis with focus on the early and late stages","volume":"32","author":"Coutant","year":"2020","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.coi.2026.102735_bib17","article-title":"IgA complexes induce neutrophil extracellular trap formation more potently than IgG complexes","volume":"12","author":"Gimpel","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2026.102735_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-02892-y","article-title":"Functionally distinct disease-associated fibroblast subsets in rheumatoid arthritis","volume":"9","author":"Mizoguchi","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2026.102735_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz5327","article-title":"Persistently activated, proliferative memory autoreactive B cells promote inflammation in rheumatoid arthritis","volume":"12","author":"Kristyanto","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coi.2026.102735_bib20","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/art.40920","article-title":"N-linked glycans in the variable domain of IgG anti-citrullinated protein antibodies predict the development of rheumatoid arthritis","volume":"71","author":"Hafkenscheid","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.coi.2026.102735_bib21","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1074\/mcp.M116.062919","article-title":"Structural analysis of variable domain glycosylation of anti-citrullinated protein antibodies in rheumatoid arthritis reveals the presence of highly sialylated glycans","volume":"16","author":"Hafkenscheid","year":"2017","journal-title":"Mol Cell Proteom"},{"key":"10.1016\/j.coi.2026.102735_sbref22","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.ard.2025.04.013","article-title":"Epitopes targeted by autoantibodies in presymptomatic individuals predict early rheumatoid arthritis","volume":"84","author":"He","year":"2025","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2026.102735_bib23","article-title":"The diagnostic and prognostic value of IgG and IgA anti-citrullinated protein antibodies in patients with early rheumatoid arthritis","volume":"13","author":"Sieghart","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2026.102735_bib24","doi-asserted-by":"crossref","first-page":"e284","DOI":"10.1016\/S2665-9913(20)30381-7","article-title":"The impact of autoantibodies against citrullinated, carbamylated, and acetylated peptides on radiographic progression in patients with new-onset rheumatoid arthritis: an observational cohort study","volume":"3","author":"Nijjar","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.coi.2026.102735_bib25","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41586-020-2222-z","article-title":"Notch signalling drives synovial fibroblast identity and arthritis pathology","volume":"582","author":"Wei","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.coi.2026.102735_sbref26","doi-asserted-by":"crossref","DOI":"10.1093\/cei\/uxaf047","article-title":"Role of a new truncated CD74 isoform in increased IL-17 secretion from stromal-immune cell interactions","volume":"219","author":"Noack","year":"2025","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.coi.2026.102735_sbref27","doi-asserted-by":"crossref","DOI":"10.1172\/JCI185217","article-title":"Deep immunophenotyping reveals circulating activated lymphocytes in individuals at risk for rheumatoid arthritis","volume":"135","author":"Inamo","year":"2025","journal-title":"J Clin Investig"},{"key":"10.1016\/j.coi.2026.102735_sbref28","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s41586-023-06708-y","article-title":"Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes","volume":"623","author":"Zhang","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.coi.2026.102735_bib29","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1056\/NEJMoa2004114","article-title":"RNA identification of PRIME cells predicting rheumatoid arthritis flares","volume":"383","author":"Orange","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2026.102735_bib30","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/rheumatology\/keae090","article-title":"Circulating Tfh cells are differentially modified by abatacept or TNF blockers and predict treatment response in rheumatoid arthritis","volume":"64","author":"Monjo-Henry","year":"2025","journal-title":"Rheumatology"},{"key":"10.1016\/j.coi.2026.102735_bib31","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.1002\/art.30599","article-title":"Blood memory B cells are disturbed and predict the response to rituximab in patients with rheumatoid arthritis","volume":"63","author":"Sellam","year":"2011","journal-title":"Arthritis Rheumtol"},{"key":"10.1016\/j.coi.2026.102735_bib32","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s40744-021-00330-y","article-title":"A molecular signature response classifier to predict inadequate response to tumor necrosis Factor-\u03b1 inhibitors: the NETWORK-004 Prospective Observational Study","volume":"8","author":"Cohen","year":"2021","journal-title":"Rheumatol Ther"},{"key":"10.1016\/j.coi.2026.102735_sbref33","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1136\/ard-2024-226228","article-title":"Peripheral blood immunophenotypic diversity in patients with rheumatoid arthritis and its impact on therapeutic responsiveness","volume":"84","author":"Kubo","year":"2025","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2026.102735_bib34","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/s41591-020-0939-8","article-title":"Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis","volume":"26","author":"Alivernini","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.coi.2026.102735_bib35","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/0167-5699(96)80615-3","article-title":"Bypassing the antigen to control rheumatoid arthritis","volume":"17","author":"Miossec","year":"1996","journal-title":"Immunol Today"},{"key":"10.1016\/j.coi.2026.102735_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00425","article-title":"Effects of interleukin-17A on osteogenic differentiation of isolated human mesenchymal stem cells","volume":"5","author":"Osta","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2026.102735_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00151","article-title":"Differential effects of IL-17A and TNF-\u03b1 on osteoblastic differentiation of isolated synoviocytes and on bone explants from arthritis patients","volume":"6","author":"Osta","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2026.102735_bib38","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/s41584-020-0413-5","article-title":"Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes","volume":"16","author":"Nygaard","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.coi.2026.102735_bib39","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1136\/annrheumdis-2021-222021","article-title":"Synovial fibroblasts as potential drug targets in rheumatoid arthritis, where do we stand and where shall we go?","volume":"81","author":"N\u00e9meth","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2026.102735_bib40","doi-asserted-by":"crossref","DOI":"10.1017\/erm.2025.11","article-title":"Unveiling the therapeutic potential: targeting fibroblast-like synoviocytes in rheumatoid arthritis","volume":"27","author":"Yue","year":"2025","journal-title":"Expert Rev Mol Med"},{"key":"10.1016\/j.coi.2026.102735_bib41","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/s41586-019-1263-7","article-title":"Distinct fibroblast subsets drive inflammation and damage in arthritis","volume":"570","author":"Croft","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.coi.2026.102735_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-00142-1","article-title":"PUMA gene delivery to synoviocytes reduces inflammation and degeneration of arthritic joints","volume":"8","author":"Hong","year":"2017","journal-title":"Nat Commun"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791526000129?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791526000129?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T09:32:43Z","timestamp":1784539963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791526000129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":42,"alternative-id":["S0952791526000129"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2026.102735","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rheumatoid arthritis: revisiting pathogenesis for prevention, stratification, and repair","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2026.102735","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102735"}}